Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.

Source:http://linkedlifedata.com/resource/pubmed/id/18311900

J. Med. Chem. 2008 Mar 27 51 6 1695-705

Download in:

View as

General Info

PMID
18311900